Drugs used for weight loss like Wegovy and Zepbound could be covered by Medicare or Medicaid under a new proposal from the Biden administration.

Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.

But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, marking it as the first treatment in the country ...

Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...

Biden's new proposal would significantly expand access to anti-obesity drugs such as Ozempic and Wegovy. Without insurance coverage, the drugs can cost as much as $1,000 a month. Lawmakers previously ...

Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...

Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic ...

Health and Human Services (HHS) has unveiled a proposal to expand Medicare and Medicaid coverage to include weight loss drugs ...

Health Canada has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of non-fatal heart attack, the drug ...

A new HHS rule would require Medicare and Medicaid to cover drugs like Wegovy or Zepbound for a large segment of Americans.

Ah, Thanksgiving: a time to gather ’round with friends and family, reflect on what we’re grateful for, and, of course, eat.